|
|
|||||||||
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. Demographic Differences in Notifiable Infectious Disease Morbidity -- United States, 1992-1994Before the 1990s, National Notifiable Diseases Surveillance System (NNDSS) data consisted primarily of summary records that lacked demographic information for persons with reported diseases. By 1990, all 50 states were using CDC's National Electronic Telecommunications System for Surveillance (NETSS) to report individual case data that included demographic information (without personal identifiers) about most nationally notifiable diseases. These data are important for evaluating sex-specific differences in the occurrence of infectious diseases; monitoring infectious disease morbidity trends; determining the relative disease burdens among demographically diverse subpopulations in the United States; targeting prevention; and identifying priorities for research and control. This report describes and compares the numbers and rates of cases for the most frequently reported nationally notifiable infectious diseases, by sex and age of persons with reported illness, reported to CDC during 1992-1994. The findings indicate that for seven of the 10 most commonly reported notifiable diseases, the reported incidence is lower among women. NNDSS data were evaluated for the 48 nationally notifiable infectious diseases * reported to CDC by state, territorial, and local health departments during 1992-1994 (1), the most recent years for which all notifiable disease data were available at the time of this analysis. Data for gonorrhea, primary/secondary syphilis, acquired immunodeficiency syndrome (AIDS), and tuberculosis (TB) were reported to CDC programs with disease-specific responsibility; other NNDSS data were derived from NETSS reports. Reports for persons for whom age or sex was unknown were not included in this analysis. Postcensal estimates from the Bureau of the Census were used to calculate age-specific and sex-specific rates (2). Children were defined as persons aged less than 15 years; adolescents, persons aged 15-19 years; and adults, persons aged greater than or equal to 20 years. Because AIDS cases were reported in a different format, persons with AIDS aged less than 13 years were defined as children and persons aged 13-19 years as adolescents. AIDS cases included in this analysis met the 1993 AIDS case definition for surveillance (3). During 1992-1994, the 10 most frequently reported nationally notifiable infectious diseases for all ages and both sexes in the United States were, in descending order, gonorrhea, AIDS, salmonellosis, shigellosis, primary and secondary syphilis, TB, hepatitis A, hepatitis B, Lyme disease, and hepatitis C/non-A, non-B. The order remained the same when reports for persons for whom age and sex were unknown were included. Although the incidence of most diseases among children were similar for males and females (Table_1), the reported incidence of gonorrhea for females (29.8 cases per 100,000 population) was more than three times that for males (8.8). For children aged 10-14 years, the reported rate of gonorrhea for females (79.3) was more than four times that for males (19.4). For adolescents, the reported incidence of gonorrhea for females (878.0) was 1.4 times that for males (627.4) (Table_1). For adolescents, there were also sex-specific differences in the incidences of primary and secondary syphilis, hepatitis B, and shigellosis; for all of these diseases, rates for females were approximately twice those for males. For adults, rates were higher among males than females for seven of the 10 most commonly reported notifiable diseases (Table_1). Reported by: Div of Public Health Surveillance and Informatics (proposed), Epidemiology Program Office, CDC. Editorial NoteEditorial Note: The findings in this analysis underscore the usefulness of reporting individual case data for evaluation of the differences in major causes of reported morbidity in the United States for both males and females of all ages. Although women use the health-care system more frequently than men (4), for seven of the 10 most commonly reported notifiable diseases the reported incidence is lower among women. Among the three broad age categories, the incidences for salmonellosis (28.2 cases per 100,000 population), shigellosis (25.9), and hepatitis A (13.5) were highest among children. Because hepatitis A virus infection in young children is often asymptomatic, the true incidence of this infectious disease among children may be substantially higher than that based on acute disease surveillance. Among adults, only for salmonellosis and shigellosis were the rates higher for women than for men. Although most cases of salmonellosis are associated with consumption of contaminated foods of animal origin, some cases are related to environmental contamination (e.g., exposure to pet reptiles {5}). Shigella sp. and hepatitis A are transmitted primarily by the fecal-oral route and are possibly related to poor personal hygiene among persons of all ages and inadequate infection-control measures in the home and workplace. Educating family members and other adults who provide care for children about proper hygiene and infection-control measures can decrease transmission of infectious diseases in the home and other settings (e.g., day care centers) (6). Appropriate use of hepatitis A vaccine in communities with increased hepatitis A rates and among persons at increased risk for infection can prevent hepatitis A (7). To prevent and control foodborne diseases, food handlers (all persons involved in production, preparation, and delivery of food to consumers) should be targeted for education about proper and frequent handwashing, safe storage and preparation of food, and the potential for serious implications (e.g., outbreaks) if food is mishandled (5). Despite the high incidence of gonorrhea among adolescent and young adult females, surveillance data probably are underestimates because of underreporting. In addition, approximately 50% of gonococcal infections among females are asymptomatic, and other infected females may not seek treatment for the infection. Therefore, appropriate screening of sexually active adolescent and adult females for gonorrhea is important for accurate surveillance as well as for prevention and control of the disease, which if untreated, can result in serious complications (e.g., pelvic inflammatory disease, infertility, and ectopic pregnancy) (8). Hepatitis B also is sexually transmitted among adolescents and adults and is preventable by hepatitis B vaccine (5). The data in this report include only the reported cases of those diseases designated as nationally notifiable. Factors affecting the representativeness of cases reported to NNDSS include underreporting; delays in reporting; misdiagnosis of disease; and differential patterns of disease detection, disease reporting, and health-care-seeking behavior. The completeness of reporting is strongly influenced by the interests, priorities, and professional and financial resources of national, state, and local officials responsible for disease control and public health surveillance (9). Although certain diseases are not considered nationally reportable, they may be leading causes of morbidity and mortality (e.g., pneumonia and influenza). For example, chlamydia was not included as a nationally notifiable disease until 1995, when it was the most frequently reported notifiable disease (10); more than 1 million cases of chlamydia were reported during 1992-1994. Analysis of the data in this report by broad age groups may obscure important differences in rates by age for some diseases. For example, the age distribution of persons reported with cases of Lyme disease is bimodal, with the highest reported incidences among children aged 5-9 years and adults aged 45-69 years and substantially lower incidences among older adolescents and young adults. Because notifiable diseases are underreported and represent only a subset of all infectious diseases, the findings in this report underscore the need for sustained efforts to improve the completeness and consistency of surveillance systems for monitoring the trends of notifiable infectious diseases. Improved understanding of the epidemiology of infectious diseases in subgroups of the U.S. population can assist public health agencies and others in strengthening measures to prevent, monitor, and control the incidence of infectious diseases. References
* Acquired immunodeficiency syndrome; amebiasis; anthrax; aseptic meningitis; botulism; brucellosis; chancroid; cholera; congenital rubella syndrome; diphtheria; primary encephalitis; Escherichia coli O157:H7; gonorrhea; granuloma inguinale; Haemophilus influenzae; hepatitis A; hepatitis B; hepatitis, non-A, non-B; hepatitis, unspecified; legionellosis; leprosy; leptospirosis; Lyme disease; lymphogranuloma venereum; malaria; measles; meningococcal infection; mumps; pertussis; plague; poliomyelitis; psittacosis; rabies, animal; rabies, human; rheumatic fever; Rocky Mountain spotted fever; rubella; salmonellosis; shigellosis; syphilis; syphilis, congenital; tetanus; toxic-shock syndrome; trichinosis; tuberculosis; tularemia; typhoid fever; and yellow fever. Table_1 Note: To print large tables and graphs users may have to change their printer settings to landscape and use a small font size. TABLE 1. Ten most commonly reported nationally notifiable infectious diseases among children, adolescents, and adults, * by sex -- United States, 1992-1994 + ================================================================================================================ Females Males Age group/ -------------------------------------------- -------------------------------------------- Rank Disease No. cases Rate & Disease No. cases Rate & -------------------------------------------------------------------------------------------------------------- Children 1 Gonorrhea @ 24,291 29.8 Salmonellosis 25,457 29.2 2 Salmonellosis 22,062 26.6 Shigellosis 22,272 25.6 3 Shigellosis 21,520 26.0 Hepatitis A 11,688 13.4 4 Hepatitis A 11,247 13.6 Gonorrhea @ 7,477 8.8 5 Pertussis 5,919 7.1 Pertussis 5,812 6.7 6 Congenital syphilis 4,367 5.3 Congenital syphilis 4,552 5.2 7 Lyme disease 2,633 3.2 Lyme disease 3,262 3.7 8 Tuberculosis 2,539 3.1 Tuberculosis 2,580 3.0 9 Meningococcal disease 1,774 2.1 Meningococcal disease 2,209 2.5 10 Mumps 1,412 1.7 Mumps 1,963 2.3 Adolescents 1 Gonorrhea @ 218,018 878.0 Gonorrhea @ 164,079 627.4 2 Primary/Secondary Primary/Secondary syphilis 5,935 23.4 syphilis 3,067 11.4 3 Hepatitis A 2,639 10.4 Hepatitis A 3,019 11.3 4 Salmonellosis 2,280 9.0 Salmonellosis 2,531 9.5 5 Hepatitis B 1,812 7.2 Hepatitis B 1,011 3.8 6 Shigellosis 1,523 6.0 Tuberculosis 870 3.3 7 Tuberculosis 840 3.3 Shigellosis 865 3.2 8 Lyme disease 631 2.5 Lyme disease 717 2.7 9 Pertussis 476 1.9 AIDS @ 683 1.8 10 AIDS @ 425 1.2 Meningococcal disease 475 1.8 Adults 1 Gonorrhea @ 344,433 122.0 Gonorrhea @ 531,384 205.2 2 AIDS 34,872 12.1 AIDS 187,211 71.0 3 Primary/Secondary Tuberculosis 46,160 17.5 syphilis 31,893 11.0 4 Salmonellosis 30,286 10.5 Primary/Secondary syphilis 39,504 15.0 5 Tuberculosis 23,184 8.1 Hepatitis A 25,729 9.8 6 Hepatitis A 18,258 6.3 Salmonellosis 24,943 9.5 7 Shigellosis 14,274 5.0 Hepatitis B 21,640 8.2 8 Hepatitis B 13,987 4.9 Lyme disease 10,152 3.9 9 Lyme disease 11,024 3.8 Hepatitis C/non-A non-B 9,413 3.6 10 Hepatitis C/non-A non-B 4,980 1.7 Shigellosis 8,054 3.1 -------------------------------------------------------------------------------------------------------------- * Children were defined as persons aged <15 years; adolescents, aged 15-19 years; and adults, aged >=20 years. For AIDS cases, children were persons aged <13 years and adolescents were persons aged 13-19 years. + Persons for whom age was not reported are excluded. & Per 100,000 population. @ Data from Georgia were excluded for 1993 because age was not reported and for 1994 because no cases were reported. ================================================================================================================ Return to top. Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Page converted: 09/19/98 |
|||||||||
This page last reviewed 5/2/01
|